<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Approximately 10% to 15% of <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancers</z:e> are hereditary or familial in nature </plain></SENT>
<SENT sid="1" pm="."><plain>For several <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorders</z:e>, the development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is a secondary manifestation of the clinical phenotype, whereas <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition syndromes are generally recognized by the manifestation of characteristic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The study of <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">pediatric cancer</z:e> and rare <z:e sem="disease" ids="C0027672" disease_type="Neoplastic Process" abbrv="">hereditary cancer syndromes</z:e> and associations has led to the identification of numerous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> genes that are known to play critical roles in both <z:mpath ids='MPATH_458'>normal</z:mpath> and abnormal cellular growth, differentiation, and proliferation </plain></SENT>
<SENT sid="3" pm="."><plain>The potential to identify such genetic markers of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition poses difficult social, legal, and ethical questions in their application to clinical practice </plain></SENT>
</text></document>